What's New at the pCPA

The new three-year pricing initiative for generic drugs will come into effect on October 1, 2023.
The agreement between the pan-Canadian Pharmaceutical Alliance (pCPA) and the Canadian Generic Pharmaceutical Association (CGPA) builds upon the successes achieved to date with the pan-Canadian Generic Tiered Pricing Framework (TPF) and the pan-Canadian molecules.

The pan-Canadian Pharmaceutical Alliance’s (pCPA) Board of Directors is excited to announce that Douglas Clark will become the first CEO of the newly incorporated organization, effective September 11, 2023

The pCPA is accepting feedback regarding the development of a set of principles and conditions that will inform the negotiation process and potential product listing agreements for any drug products that follow the CADTH time-limited recommendation pathway.

The pan-Canadian Pharmaceutical Alliance is continuing the transition to a stand-alone organization including recruiting key leaders and ensuring all necessary operational supports are in place.